What is your preferred imaging modality--cMR vs. TTE--to evaluate for myocardial strain if concerned for chemotherapy-induced cardiomyopathies?

Per American guidelines, TTE with strain would be indicated at baseline and then every 3-6 months while on chemotherapy. No cMR per American guidelines for routine screening/follow-up to the best of my knowledge.